In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Lilly announces amendment to merger agreement with ICOS
Eli Lilly and Company (LLY) to acquire ICOS Corporation (ICOS) for $2.1 billion
Lilly Announces Completion of ICOS Corporation Acquisition
Eli Lilly Extends Cooperation with Optimata, Developer of Virtual Patient Technology
Iconix announces collaborative relationship with Icos
ICOS to manufacture clinical candidate for Protein Design Labs
ICOS and Raven Biotechnologies Enter Exclusive Collaboration for Antibody Therapeutics